ReproCELL Statistics
Total Valuation
ReproCELL has a market cap or net worth of JPY 11.21 billion. The enterprise value is 5.36 billion.
Important Dates
The last earnings date was Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ReproCELL has 106.76 million shares outstanding. The number of shares has increased by 2.23% in one year.
| Current Share Class | 106.76M |
| Shares Outstanding | 106.76M |
| Shares Change (YoY) | +2.23% |
| Shares Change (QoQ) | +5.92% |
| Owned by Insiders (%) | 4.43% |
| Owned by Institutions (%) | 7.61% |
| Float | 102.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.69 |
| PB Ratio | 1.10 |
| P/TBV Ratio | 1.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.01, with zero debt.
| Current Ratio | 12.01 |
| Quick Ratio | 11.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -4.47% and return on invested capital (ROIC) is -5.35%.
| Return on Equity (ROE) | -4.47% |
| Return on Assets (ROA) | -4.90% |
| Return on Invested Capital (ROIC) | -5.35% |
| Return on Capital Employed (ROCE) | -7.52% |
| Weighted Average Cost of Capital (WACC) | 7.47% |
| Revenue Per Employee | 23.91M |
| Profits Per Employee | -4.20M |
| Employee Count | 101 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 4.10 |
Taxes
In the past 12 months, ReproCELL has paid 2.00 million in taxes.
| Income Tax | 2.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.48% in the last 52 weeks. The beta is 0.59, so ReproCELL's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | -32.48% |
| 50-Day Moving Average | 127.58 |
| 200-Day Moving Average | 146.33 |
| Relative Strength Index (RSI) | 33.28 |
| Average Volume (20 Days) | 821,010 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ReproCELL had revenue of JPY 2.42 billion and -424.00 million in losses. Loss per share was -4.39.
| Revenue | 2.42B |
| Gross Profit | 1.20B |
| Operating Income | -811.00M |
| Pretax Income | -422.00M |
| Net Income | -424.00M |
| EBITDA | -730.00M |
| EBIT | -811.00M |
| Loss Per Share | -4.39 |
Full Income Statement Balance Sheet
The company has 5.85 billion in cash and no debt, with a net cash position of 5.85 billion or 54.80 per share.
| Cash & Cash Equivalents | 5.85B |
| Total Debt | n/a |
| Net Cash | 5.85B |
| Net Cash Per Share | 54.80 |
| Equity (Book Value) | 10.29B |
| Book Value Per Share | 101.52 |
| Working Capital | 6.17B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -384.00 million and capital expenditures -77.00 million, giving a free cash flow of -461.00 million.
| Operating Cash Flow | -384.00M |
| Capital Expenditures | -77.00M |
| Depreciation & Amortization | 81.00M |
| Net Borrowing | n/a |
| Free Cash Flow | -461.00M |
| FCF Per Share | -4.32 |
Full Cash Flow Statement Margins
Gross margin is 49.52%, with operating and profit margins of -33.58% and -17.56%.
| Gross Margin | 49.52% |
| Operating Margin | -33.58% |
| Pretax Margin | -17.47% |
| Profit Margin | -17.56% |
| EBITDA Margin | -30.23% |
| EBIT Margin | -33.58% |
| FCF Margin | n/a |
Dividends & Yields
ReproCELL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.23% |
| Shareholder Yield | -2.23% |
| Earnings Yield | -4.18% |
| FCF Yield | -4.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on August 28, 2013. It was a forward split with a ratio of 5.
| Last Split Date | Aug 28, 2013 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
ReproCELL has an Altman Z-Score of 9.16 and a Piotroski F-Score of 2.
| Altman Z-Score | 9.16 |
| Piotroski F-Score | 2 |